Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlenveagh Regulatory News (GLV)

Share Price Information for Glenveagh (GLV)

Share Price is delayed by 15 minutes
Get Live Data
2.36    0.00 (0.00%)
Bid:
2.22
Ask:
2.50
Spread: 0.28 (12.613%)
Market Cap: €1.22b
GLV Live PriceLast checked at - London Stock Exchange

Intraday Glenveagh Share Chart

CFO Transition

5 Sep 2024 07:05

RNS Number : 9715C
Glenveagh Properties plc
05 September 2024
 

 

 

5 September 2024

 

Glenveagh Properties plc

Glenveagh Properties plc Announces CFO Transition

Glenveagh Properties plc ("Glenveagh" or the "Group") a leading Irish homebuilder today announces that Michael Rice has informed the Board that he is stepping down from his role as Executive Director and Chief Financial Officer ("CFO") of Glenveagh to pursue other interests. Michael will step down from the Board on 31 December 2024 but will remain with Glenveagh into 2025 to ensure a smooth transition.

Michael will be succeeded in the role of CFO by Conor Murtagh, who is currently Chief Strategy Officer and a member of the Group's Executive Committee. As part of the CFO transition period, the Board will undertake a nomination process in respect of Conor's potential appointment as an Executive Director.

Stephen Garvey said:

I would like to express my deep appreciation for Michael, whose unwavering dedication and exceptional expertise over the past seven years have played a pivotal role in advancing our company to its current position. His hard work and commitment have not only contributed significantly to our success but have also set a strong foundation for the future. We owe much of our progress to his efforts, and we all here at Glenveagh wish him the very best in all his future endeavours.

I am delighted that Conor has agreed to continue to work with the business in the capacity of CFO. Over the past six years, Conor has been a vital part of Glenveagh, consistently demonstrating exceptional leadership, dedication, and a deep understanding of our business and its success drivers. I am confident that Conor will continue to play a crucial role in driving our future success."

Michael Rice added:

"I would like to thank the Board, Stephen and the rest of the senior management team for their support in my time as CFO and Director of Glenveagh and I am very proud of what we have achieved together over the last seven years. I feel now is the right time to move on to new challenges and opportunities. I have every confidence in the future success of the business, and I wish the team the very best for the future."

Conor Murtagh added:

I am excited to assume the role of CFO at Glenveagh. Over the years, I have had the privilege of working closely with the exceptional team at Glenveagh, and I am committed to advancing our shared vision and building on the strong foundation we have established.

ENDS

 

Notes to editors: 

About Conor Murtagh:

Conor joined Glenveagh in 2018 as Director of Strategy & IR and was appointed Chief Strategy Officer in 2021 where he led the group's Strategy and Corporate Development efforts alongside responsibility for People, L&D and Environmental Health & Safety and Sustainability. Conor joined Glenveagh with over 10 years corporate finance experience from Investec where he advised corporates, PLCs and private equity clients on mergers and acquisitions, disposals, fundraisings and financings.

A fellow of the Association of Chartered Certified Accountants, Conor holds a BBS (Hons, 1st class) in Business Studies from Dublin City University.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFFFFIAEISIIS
Date   Source Headline
27th Aug 20247:00 amRNSNotice of Interim Results 2024
21st Aug 202410:02 amRNSHolding(s) in Company
1st Aug 20249:49 amRNSTotal Voting Rights
4th Jul 20247:00 amRNSH1 Trading Statement 2024
1st Jul 202410:18 amRNSTotal Voting Rights
28th Jun 20243:21 pmRNSHolding(s) in Company
26th Jun 20244:48 pmRNSNotice of H1 Trading Statement 2024
14th Jun 202410:21 amRNSChanges to Board Committee Composition
4th Jun 20249:30 amRNSHolding(s) in Company
4th Jun 20249:25 amRNSTotal Voting Rights
28th May 20243:06 pmRNSHolding(s) in Company
8th May 20247:00 amRNSAppointment of Joint Corporate Broker
7th May 20243:58 pmRNSHolding(s) in Company
3rd May 20242:15 pmRNSAwards under the Glenveagh Properties plc LTIP
3rd May 20248:48 amRNSHolding(s) in Company
2nd May 20242:58 pmRNSResult of AGM
2nd May 20247:00 amRNSTrading Statement
1st May 202410:39 amRNSTotal Voting Rights
29th Apr 20249:23 amRNSDirector/PDMR Shareholding
12th Apr 202412:24 pmRNSHolding(s) in Company
4th Apr 20244:24 pmRNSHolding(s) in Company
2nd Apr 20246:08 pmRNSBlock listing Interim Review
2nd Apr 20244:47 pmRNSDirector/PDMR Shareholding
2nd Apr 20244:44 pmRNSDirector/PDMR Shareholding
2nd Apr 20249:01 amRNSTotal Voting Rights
28th Mar 20245:27 pmRNSDirector/PDMR Shareholding
27th Mar 20247:00 amRNSBlock Listing Application
25th Mar 202411:57 amRNSTotal Voting Rights
25th Mar 202411:48 amRNSPosting of Annual Report and Notice of AGM
1st Mar 20249:28 amRNSTotal Voting Rights
28th Feb 20247:00 amRNSFinal Results 2023
16th Feb 20249:23 amRNSNotice of Results
1st Feb 202410:56 amRNSTotal Voting Rights
30th Jan 20243:24 pmRNSHolding(s) in Company
29th Jan 20245:28 pmRNSHolding(s) in Company
15th Jan 202412:46 pmRNSHolding(s) in Company
10th Jan 20247:02 amRNSAppointment of Two New Non-Executive Directors
10th Jan 20247:00 amRNSFull Year Trading Statement 2023
5th Jan 202411:45 amRNSHolding(s) in Company
2nd Jan 20249:47 amRNSTotal Voting Rights
15th Dec 20231:42 pmRNSNotice of Full-Year Trading Statement 2023
13th Dec 20236:04 pmRNSHolding(s) in Company
13th Dec 20234:19 pmRNSHolding(s) in Company
12th Dec 20232:47 pmRNSHolding(s) in Company
12th Dec 20239:30 amRNSDirector/PDMR Shareholding
6th Dec 20239:46 amRNSHolding(s) in Company
6th Dec 20239:40 amRNSHolding(s) in Company
5th Dec 202310:58 amRNSHolding(s) in Company
1st Dec 20238:31 amRNSTotal Voting Rights
1st Nov 20239:43 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.